Phibro Animal Health Corporation Class A

XNASHealth care

Last traded price · USD

$42.55

+7.91%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $39.43
Volume: 4,003
Day's high: —
Day's low: —

In brief

Phibro Animal Health Corporation is a health care company listed on Nasdaq, valued at about $1.73B.
Its shares closed at $39.43 on 4 Nov 2026, down 6.4% over the past year.
From India you can buy PAHC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Phibro Animal Health Corporation (PAHC) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole PAHC share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade PAHC options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +7.7% (SPY −1.6%, XLV +13.5%). 3 months: +9.5% (SPY −0.4%, XLV +15.5%). 1 year: −6.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PAHC, SPY and XLV · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $39.43 was 6.1% above its 50-day average ($37.16) and 4.4% below its 200-day average ($41.23). It has closed below the 200-day for 125 sessions, since 8 May 2026. The 50-day average crossed below the 200-day on 16 Jun 2026, 98 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
35% of the way up its 52-week range
Closed at $39.43 on 4 Nov 2026: 34.4% below the 52-week high of $60.08 (13 Apr 2026) and 39.6% above the low of $28.25 (2 Jun 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 4.9% of shares outstanding
1.0M shares were sold short at the 15 Oct 2026 settlement, 4.9% of the 21.1M shares outstanding; covering them would take 4.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+7.7%

6 months−32.6%

1 year−6.4%

5 years+80.5%

Newswire

About

Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.

Website

Notable moves

May 7, 2026
−26.22%
February 5, 2026
+21.95%
April 29, 2024
+31.81%

Newswire

About

Website

Notable moves

May 7, 2026
−26.22%
February 5, 2026
+21.95%
April 29, 2024
+31.81%

Phibro Animal Health Corporation Class A

XNASHealth care

Last traded price · USD

$42.55

+7.91%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $39.43
Volume: 4,003
Day's high: —
Day's low: —

In brief

Phibro Animal Health Corporation is a health care company listed on Nasdaq, valued at about $1.73B.
Its shares closed at $39.43 on 4 Nov 2026, down 6.4% over the past year.
From India you can buy PAHC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Phibro Animal Health Corporation (PAHC) shares from India?

Do I need the price of a whole PAHC share to invest?

How much can I invest in US stocks in a year?

Can I trade PAHC options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +7.7% (SPY −1.6%, XLV +13.5%). 3 months: +9.5% (SPY −0.4%, XLV +15.5%). 1 year: −6.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PAHC, SPY and XLV · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $39.43 was 6.1% above its 50-day average ($37.16) and 4.4% below its 200-day average ($41.23). It has closed below the 200-day for 125 sessions, since 8 May 2026. The 50-day average crossed below the 200-day on 16 Jun 2026, 98 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
35% of the way up its 52-week range
Closed at $39.43 on 4 Nov 2026: 34.4% below the 52-week high of $60.08 (13 Apr 2026) and 39.6% above the low of $28.25 (2 Jun 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 4.9% of shares outstanding
1.0M shares were sold short at the 15 Oct 2026 settlement, 4.9% of the 21.1M shares outstanding; covering them would take 4.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+7.7%

6 months−32.6%

1 year−6.4%

5 years+80.5%

Newswire

About

Website

Notable moves

May 7, 2026
−26.22%
February 5, 2026
+21.95%
April 29, 2024
+31.81%

Newswire

About

Website

Notable moves

May 7, 2026
−26.22%
February 5, 2026
+21.95%
April 29, 2024
+31.81%

Phibro Animal Health Corporation Class A

Phibro Animal Health Corporation in brief

Behind SPY and its sector fund XLV over 1 year

Above its 50-day average, below its 200-day

35% of the way up its 52-week range

Short interest at 4.9% of shares outstanding

Phibro Animal Health Corporation Class A

Phibro Animal Health Corporation in brief

Behind SPY and its sector fund XLV over 1 year

Above its 50-day average, below its 200-day

35% of the way up its 52-week range

Short interest at 4.9% of shares outstanding